Today Jeff and Iyaz challenge the ideas and proof of concepts disclosed at Microsoft's Windows 10 press conference earlier in the week. They also cover a wide range of categories from DeflateGate, pharmaceutical ads on TV, the films of 2014 and much more -- all while Jeff slowly looses his voice.
The chipmaker won't contest the record fine as part of the resolution, and agrees to make several changes to its patent-licensing business in China.
Researchers at Duke University have grown the first ever human muscle in a lab that contracts just like naturally grown tissue.
Selling consumers a multipurpose wearable device is clashing with the idea of cheaper, single-serving products. At CES 2015, companies are eager to figure out the future.
The two companies have collided on everything from drones to acquisitions to search. And the competition between the tech titans isn't slowing down.
Dot-com? How quaint. A smorgasbord of new Net domains has arrived, with hundreds more on the way. There's opportunity aplenty, but lots of trademark hassles, too.
On the heels of Apple and Samsung, Facebook is plotting its first steps into the health-care industry.
Researchers develop a pill that could be swallowed to deliver drugs directly into our digestive tracts via tiny needles. And that's better how?
The search giant takes another step into biotech, snapping up a device maker focused on neurodegenerative diseases.
The Google-backed company is taking its mission to extend the human life span further, partnering with biopharmaceutical firm AbbVie.